The nonlipid effects of statins on endothelial function

被引：51

作者：

Beckman, Joshua A. ^{[1
]}

Creager, Mark A. ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA

来源：

TRENDS IN CARDIOVASCULAR MEDICINE | 2006年 / 16卷 / 05期

关键词：

D O I：

10.1016/j.tcm.2006.03.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Hydroxymethylglutaryl-coenzyme A reductase inhibitors or statins constitute one of the wonder drugs of the last 2 decades. Use of this hypolipidemic medication class reduces morbidity and mortality in patients with a wide variety of cholesterol levels. Beneficial effects of the medication are seen in advance of changes in lipids suggesting nonlipid mechanisms may play a role in mediating these benefits of statins. One important nonlipid mechanism by which statins may improve vascular outcomes is restoration of normal endothelial cell function. This review will discuss the nonlipid effects of statins on endothelial cell function to highlight other avenues of benefit conferred by these medications.

引用

页码：156 / 162

页数：7

共 89 条

[51] Fluvastatin reduces endothelin secretion of cultured human umbilical vein endothelial cells
Mueck, AO
Seeger, H
Lippert, TH
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (09) : 625 - 626
[52] Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: A double-blind study
Mullen, MJ
Wright, D
Donald, AE
Thorne, S
Thomson, H
Deanfield, JE
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) : 410 - +
[53] Effect of cerivastatin on urinary albumin excretion and plasma endothelin-1 concentrations in type 2 diabetes patients with microalbuminuria and dyslipidemia
Nakamura, T
Ushiyama, C
Hirokawa, K
Osada, S
Shimada, N
Koide, H
[J]. AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (06) : 449 - 454
[54] Nawawi H, 2003, HORM METAB RES, V35, P479
[55] Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
Nissen, SE
Tuzcu, EM
Schoenhagen, P
Brown, BG
Ganz, P
Vogel, RA
Crowe, T
Howard, G
Cooper, CJ
Brodie, B
Grines, CL
DeMaria, AN
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (09): : 1071 - 1080
[56] Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month
ODriscoll, G
Green, D
Taylor, RR
[J]. CIRCULATION, 1997, 95 (05) : 1126 - 1131
[57] Statins inhibit high glucose-mediated neutrophil-endothelial cell adhesion through decreasing surface expression of endothelial adhesion molecules by stimulating production of endothelial nitric oxide
Omi, H
Okayama, N
Shimizu, M
Fukutomi, T
Imaeda, K
Okouchi, M
Itoh, M
[J]. MICROVASCULAR RESEARCH, 2003, 65 (02) : 118 - 124
[58] Direct in vivo evidence of a vascular statin:: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects
Omori, H
Nagashima, H
Tsurumi, Y
Takagi, A
Ishizuka, N
Hagiwara, N
Kawana, M
Kasanuki, H
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 395 - 396
[59] The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients
Örem, C
Uydu, HA
Yilmaz, R
Gokçe, M
Baykan, M
Eminagaoglu, S
Örem, A
[J]. JAPANESE HEART JOURNAL, 2004, 45 (06): : 977 - 987
[60] The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction
Ostadal, P
Alan, D
Hajek, P
Horak, D
Vejvoda, J
Trefanec, J
Mates, M
Vojacek, J
[J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 246 (1-2) : 45 - 50

← 1 2 3 4 5 6 7 8 9 →